Outcomes in Four Children with Persistent, Recurrent, and Progressive Gangliogliomas Treated in Phase II Studies with Antineoplastons A10 and AS2-1
Burzynski Stanislaw, Burzynski Gregory, Janicki Tomasz, Beenken Samuel
Burzynski S, Burzynski G, Janicki T, Beenken S. Outcomes in Four Children with Persistent,
Recurrent, and Progressive Gangliogliomas Treated in Phase II Studies with Antineoplastons A10 and
AS2-1 Neurol Neurosci. 2022; 3(3):1-9
